Topalian Suzanne Louise bought VIR
October 27, 2026 · Form 4 insider transaction
Topalian Suzanne Louise bought 8,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$0.00
Total value
N/A
InsiderTopalian Suzanne Louise
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 27, 2026
Filing dateOctober 28, 2026
Shares owned after8,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.; 1/3 of the RSUs will vest on October 27, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.